Literature DB >> 8087178

Clinical criteria for vascular dementia: the NINDS-AIREN criteria.

T Erkinjuntti1.   

Abstract

Vascular dementia (VAD) is the second most common cause of dementia. In addition, cerebrovascular disease (CVD) coexists with other causes, including Alzheimer's disease. Cognitive impairment related to CVD may be preventable, and these patients could benefit from therapy. This emphasizes the need for early detection, diagnostic consistency and accuracy of the clinical diagnosis of VAD. A number of current limitations in our knowledge about VAD have restricted the construction of clinical criteria, especially the concept of a behavioral syndrome due to vascular factors affecting the brain, and the main pathophysiological factors related to VAD. The latter include the type, extent, location and tempo of vascular brain lesions, as well as the causality between brain lesions and cognitive impairment. However, relevant information on VAD is beginning to emerge. The NINDS-AIREN Workshop on VAD made an attempt to facilitate international discussion and cooperation by defining consequences of CVD and the criteria for the VAD syndrome, for epidemiological and clinical studies. Here the concepts, pathophysiological factors, current conceptual barriers, and the criteria for the clinical diagnosis are reviewed.

Entities:  

Mesh:

Year:  1994        PMID: 8087178     DOI: 10.1159/000106721

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  30 in total

Review 1.  Neuroradiological findings in vascular dementia.

Authors:  Ali Guermazi; Yves Miaux; Alex Rovira-Cañellas; Joyce Suhy; Jon Pauls; Ria Lopez; Holly Posner
Journal:  Neuroradiology       Date:  2006-11-18       Impact factor: 2.804

2.  Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease.

Authors:  I Lavenu; F Pasquier; F Lebert; B Jacob; H Petit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

3.  Personality and risk for Alzheimer's disease in adults 72 years of age and older: a 6-year follow-up.

Authors:  Paul R Duberstein; Benjamin P Chapman; Hilary A Tindle; Kaycee M Sink; Patricia Bamonti; John Robbins; Anthony F Jerant; Peter Franks
Journal:  Psychol Aging       Date:  2011-06

Review 4.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

5.  Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment.

Authors:  Qianhua Zhao; Qihao Guo; Zhen Hong
Journal:  Neurosci Bull       Date:  2013-01-15       Impact factor: 5.203

Review 6.  Vascular cognitive impairment.

Authors:  Muhammad U Farooq; Philip B Gorelick
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

7.  Small vessel disease and subcortical vascular dementia.

Authors:  Raj N Kalaria; Timo Erkinjuntti
Journal:  J Clin Neurol       Date:  2006-03-20       Impact factor: 3.077

8.  Research protocol of the NeedYD-study (Needs in Young onset Dementia): a prospective cohort study on the needs and course of early onset dementia.

Authors:  Deliane van Vliet; Christian Bakker; Raymond T C M Koopmans; Myrra J F J Vernooij-Dassen; Frans R J Verhey; Marjolein E de Vugt
Journal:  BMC Geriatr       Date:  2010-03-12       Impact factor: 3.921

9.  Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease.

Authors:  Ilan Dar-Nimrod; Benjamin P Chapman; Peter Franks; John Robbins; Anton Porsteinsson; Mark Mapstone; Paul R Duberstein
Journal:  Am J Geriatr Psychiatry       Date:  2012-12       Impact factor: 4.105

Review 10.  Key neuroanatomical structures for post-stroke cognitive impairment.

Authors:  Rebecca Grysiewicz; Philip B Gorelick
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.